MedTrace Logo

Psychometric Validation of the Competitive Attention Test

NCT03942835 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-11-01

No results posted yet for this study

Summary

This project aims at validating a new neuropsychological test to measure voluntary and involuntary attention for clinical use to diagnose attentional deficits.

This project proposes:

* a test-retest procedure in healthy subjects aged from 6 to 90 year-old;
* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment;
* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

OTHER

experience 1 : Competitive attention test in healthy participants

Comparison of behavioral measures (reaction times and percentage of correct responses) obtained twice with the CAT test in healthy participants (2 to 6 weeks apart).

OTHER

experience 2 : Competitive attention test in patients with ADHD with no treatment

Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.

OTHER

experience 3 :Competitive attention test in patients with ADHD with psychostimulant treatment

Behavioral (reaction times and percentage of correct responses) and EEG measures obtained with the CAT test in patients with ADHD before and after psychostimulant treatment.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2021-03-20
Completion
2021-04-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942835 on ClinicalTrials.gov